A landmark year in 3D Spatial Biology

A landmark year in 3D Spatial Biology

As we close the year, we want to recognize that this has been a landmark year for 3D spatial biology and Alpenglow Biosciences, with growing recognition and exciting progress.

Here are a few highlights:

  • Innovative Solutions: We launched the 3D Derm Score and 3D I/O Pro, which deliver unmatched tissue-to-insight capabilities and complete impactful research and clinical studies.
  • Funding Milestone: In August, we secured $24M+ in ARPA-H and NIH Contracts, bolstering innovation in 3D spatial biology.
  • Community Building: We participated in several congresses and meetings, including AID, AAD, PMWC, AACR, SID, EACR, EADV, SITC, and MultiOmics. We sincerely thank you for these discussions and for starting significant initiatives with us. Thanks to our excellent speakers, we successfully hosted Dinner Lectures at AACR and SITC?and?the second annual 3D Spatial Summit, bringing together brilliant minds to advance 3D spatial imaging, digital pathology, and AI.
  • Featured in Nature: A November spotlight underscored (3D) spatial biology’s transformative ability to reveal cellular interactions and redefine diagnostics. Anticipated from a unique Nature Methods print featuring an entire section on 3D histology emphasizing the importance of analyzing tissues in their full 3D context.
  • Recognition: We’re honored to be recognized as a rising leader in spatial biology. Our pioneering approach to 3D imaging and spatial data analysis unlocks unprecedented insights into tissue biology and pushes the boundaries of biomedical research.
  • CEO Highlights: Our CEO,? MD, MPH, has had an incredible year representing Alpenglow at key events, including speaking at the NRG 2024 Oncology Winter Meeting and discussing "The Role of Spatial Biology in Oncology." Showcasing innovations at the AI session during Life Science Innovation Northwest 2024, highlighting how AI accelerates drug development by extracting spatial data from 3D biopsies. Participating in the Danaher Corporation AI Summit on the “From Pixels to Intelligence” panel to discuss AI’s transformative role in pathology.

Explore Our Updated Website

We’re excited to announce that our website has been completely updated with new sections, amazing videos, detailed use cases, a wealth of literature, and our webinars and expert talks. It’s now easier than ever to explore how 3D spatial biology transforms research and clinical applications. We invite you to visit and discover the latest innovations in our field.

These accomplishments are just the beginning. We look forward to connecting and discussing exciting opportunities for 2025.

Exciting Events to Start 2025

We’re kicking off the year with a?live webinar on January 9.?In this interactive session, we’ll explore the transformative applications of 3D imaging in dermatological analysis and showcase how our technology advances precision in skin research and diagnostics.

Following the webinar on January 12, our CEO, Nicholas Reder, will take the stage at the Dermatology Summit to present Alpenglow Biosciences’ cutting-edge innovations. He’ll share our vision for the future of dermatological analysis, emphasizing how 3D imaging unlocks unprecedented insights into tissue biology and enables groundbreaking advancements in the field. These events promise to set the tone for an exciting and impactful year ahead.

We wish everyone happy holidays and a terrific New Year!

Let us know your highlights from this year!

Alpenglow Biosciences Team

Steve Pemberton

Senior Vice President of Commercial Development @ Alpenglow Biosciences turning science into revenue | Commercial Strategy | Business Development | Marketing | Sales Leadership | AI | Machine Learning data analysis

2 个月

An amazing year of seeing biology like never before!

要查看或添加评论,请登录

Alpenglow Biosciences的更多文章

社区洞察

其他会员也浏览了